NL-OMON44113已完成不适用
Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies - SPRINTT
Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Participants have to be willing to be randomised to either intervention group and to follow study protocol
- •- Men and women
- •- Aged 70 years and older
- •- SPPB score ranging between 3 (included) and 9 (included)
- •- Ability to complete 400-m walk test within 15 minutes without sitting down, the help of another person or the use of a walker
- •- Presence of low muscle mass according to results from a DXA scan and in agreement with the Foundation for the National Institutes of Health Sarcopenia Project (FNIH) reports.
排除标准
- •- Unable or unwilling to provide informed consent or accept randomisation in either study group
- •- Plans to relocate out of the study area within the next 2 years or plans to be out of the study area for more than 6 consecutive weeks in the next year
- •- Nursing-home residence
- •- Household member enrolled in the study
- •- Current diagnosis of schizophrenia, other psychotic or bipolar disorder
- •- Consumption of more than 14 alcoholic drinks per week
- •- Difficulty communicating with the study personnel due to speech, language, or (non-corrected) hearing problems
- •- MMSE lower than 24/30
- •- Severe arthritis (e.g., awaiting joint replacement) that would interfere with the ability to participate fully in either study arm
- •- Cancer requiring treatment in the past 3 years, except for non-melanoma skin cancers or cancers that have an excellent prognosis (e.g., early stage breast or prostate cancer)
- •- Lung disease requiring regular use of supplemental oxygen
- •- Inflammatory conditions requiring regular use of oral or parenteral corticosteroid agents
- •- Severe cardiovascular disease (including New York Heart Association [NYHA] class III or IV congestive heart failure, clinically significant valvular disease, history of cardiac arrest, presence of an implantable defibrillator, or uncontrolled angina)
- •- Upper and/or lower extremity amputation
- •- Peripheral arterial disease Lériche-Fontaine 3 or 4
- •- Parkinson*s disease or other progressive neurological disorder
- •- Renal disease requiring dialysis
- •- Chest pain, severe shortness of breath, or occurrence of other safety concerns during the baseline 400-metre walk test
- •- Current participation in a structured PA program, physical therapy or cardiopulmonary rehabilitation
- •- Current enrolment in another RCT involving lifestyle, nutrition, or pharmaceutical interventions
- •- Other medical, psychiatric, or behavioural factors that in the judgment of the principal investigator may interfere with the study participation or the ability to autonomously follow either the MCI or the HALE programmes
- •- Other illness of such severity that life expectancy is expected to be less than 12 months
- •- Clinical judgment concerning safety or non-compliance
研究者
相似试验
已完成
3 期
Effect of physical activity in sarcopenic elderly among community-dwellingelderly with and without sarcopeniaphysical activity, sarcopenia, elderly, community-dwelling, cardio-respiratory performance, inflammatory markersTCTR20201023002ational Research Council of Thailand90
尚未招募
不适用
Sarkopenia and physical activity in acute geriatric psychiatryVascular dementiaF32F33F31F00F01F02F03F05.1Depressive episodeRecurrent depressive disorderBipolar affective disorderDementia in Alzheimer diseaseDementia in other diseases classified elsewhereUnspecified dementiaDelirium superimposed on dementiaDRKS00033662VR-Klinik Köln150
已完成
不适用
SArcopenia Prevalence in Frail Older Adults. SAF StudyAgingNCT02903992University Hospital, Toulouse225
招募中
Unknown
FRIENDLY (Frailty and Sarcopenia survey in Elderly) StudyPatients attending our medical centerJPRN-UMIN000051021Juntendo University500
尚未招募
不适用
evaluation of frailty and sarcopenia in geriatric malignant patients of urologygeriatric malignant patients of urologyJPRN-UMIN000024299Kansai Medical University Urology and andrology100